Article Text

Download PDFPDF
Heparin dose during percutaneous coronary intervention: how low dare we go?
  1. G Niccoli,
  2. A P Banning
  1. Department of Cardiology, John Radcliffe Hospital, Headington, Oxford, UK
  1. Correspondence to:
    Dr Adrian P Banning, Department of Cardiology, John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK;
    adrian.banning{at}orh.anglox.nhs.uk

Abstract

Despite dramatic advances in percutaneous coronary intervention, including coronary stents and potent antiplatelet agents, unfractionated heparin remains the standard procedural anticoagulant. Tradition and habit may have considerable influence over dose selection. A review of the role and dosage of heparin during PCI appears to be overdue

  • heparin dosing
  • percutaneous coronary intervention
  • ACT, activated clotting time
  • aPTT, activated partial thromboplastin time
  • HMT, heparin management test
  • PCI, percutaneous coronary intervention
  • UFH, unfractioned heparin

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.